KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Share-based Compensation: 2013-2025

Historic Share-based Compensation for CareDx (CDNA) over the last 13 years, with Sep 2025 value amounting to $8.4 million.

  • CareDx's Share-based Compensation fell 50.26% to $8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.3 million, marking a year-over-year decrease of 27.69%. This contributed to the annual value of $66.4 million for FY2024, which is 35.29% up from last year.
  • Latest data reveals that CareDx reported Share-based Compensation of $8.4 million as of Q3 2025, which was down 10.67% from $9.4 million recorded in Q2 2025.
  • Over the past 5 years, CareDx's Share-based Compensation peaked at $16.9 million during Q3 2024, and registered a low of $6.5 million during Q1 2021.
  • For the 3-year period, CareDx's Share-based Compensation averaged around $12.9 million, with its median value being $12.7 million (2023).
  • As far as peak fluctuations go, CareDx's Share-based Compensation soared by 65.76% in 2024, and later plummeted by 50.26% in 2025.
  • Quarterly analysis of 5 years shows CareDx's Share-based Compensation stood at $9.5 million in 2021, then increased by 27.67% to $12.1 million in 2022, then dropped by 17.85% to $10.0 million in 2023, then spiked by 65.76% to $16.5 million in 2024, then slumped by 50.26% to $8.4 million in 2025.
  • Its last three reported values are $8.4 million in Q3 2025, $9.4 million for Q2 2025, and $8.9 million during Q1 2025.